Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 710,097,856
  • Shares Outstanding, K 949,316
  • Annual Sales, $ 34,124 M
  • Annual Income, $ 5,240 M
  • EBIT $ 13,467 M
  • EBITDA $ 14,994 M
  • 60-Month Beta 0.43
  • Price/Sales 20.86
  • Price/Cash Flow 98.33
  • Price/Book 49.71

Options Overview Details

View History
  • Implied Volatility 37.17% ( +0.93%)
  • Historical Volatility 34.10%
  • IV Percentile 85%
  • IV Rank 45.10%
  • IV High 55.08% on 08/05/24
  • IV Low 22.46% on 06/28/24
  • Put/Call Vol Ratio 0.57
  • Today's Volume 50,800
  • Volume Avg (30-Day) 69,795
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 372,186
  • Open Int (30-Day) 326,319

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 5.48
  • Number of Estimates 8
  • High Estimate 5.59
  • Low Estimate 5.34
  • Prior Year 2.49
  • Growth Rate Est. (year over year) +120.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
711.40 +5.15%
on 11/18/24
907.98 -17.62%
on 10/29/24
-161.14 (-17.72%)
since 10/22/24
3-Month
711.40 +5.15%
on 11/18/24
972.48 -23.08%
on 08/27/24
-206.16 (-21.61%)
since 08/22/24
52-Week
561.65 +33.18%
on 12/15/23
972.53 -23.09%
on 08/22/24
+152.92 (+25.70%)
since 11/22/23

Most Recent Stories

More News
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?

After flying high during the first half of the year, pharmaceutical giant Eli Lilly (NYSE: LLY) has lost some momentum; the company's shares are down by 11% since June 1. However, the healthcare leader...

LLY : 748.01 (-0.25%)
Here's How Much You Would Need to Invest in This Unstoppable Vanguard ETF Today to Grow Your Portfolio to $1 Million or More by Retirement

Investing in growth stocks can be a great strategy for building up your portfolio. But picking the best ones to buy is not necessarily easy. It wasn't all that long ago that metaverse stocks were all the...

MSFT : 417.00 (+1.00%)
NVDA : 141.95 (-3.22%)
AAPL : 229.87 (+0.59%)
LLY : 748.01 (-0.25%)
VOOG : 359.01 (-0.08%)
Will Chip Giant Broadcom Be the Next $1 Trillion Company?

Worldwide, there are currently nine companies with market capitalizations of $1 trillion or higher. Taiwan Semiconductor Manufacturing (NYSE: TSM) fluctuates between crossing that threshold based on daily...

AVGO : 164.23 (+0.18%)
JPM : 248.55 (+1.55%)
LLY : 748.01 (-0.25%)
TSM : 190.08 (-0.61%)
WMT : 90.44 (+2.32%)
2 Incredible Growth Stocks to Buy With $1,000 Right Now

It's always a great time to invest in quality businesses that can prime your portfolio for long-term growth. It's important to be selective with the companies that you add to your portfolio and ensure...

MNDY : 284.59 (+3.02%)
LLY : 748.01 (-0.25%)
Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View

This week Novartis NVS upgraded its mid-term sales growth guidance. The European Commission approved Pfizer’s PFE hemophilia drug Hympavzi (marstacimab). AstraZeneca’s AZN Tagrisso was recommended...

AZN : 65.63 (+2.13%)
JNJ : 155.17 (-0.21%)
LLY : 748.01 (-0.25%)
NVS : 104.28 (+0.41%)
PFE : 25.65 (+2.07%)
Investing in Pharma Stocks? Check These 3 Things First

The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and frequently in the face of market fluctuations as well, pharma stocks can serve...

LLY : 748.01 (-0.25%)
AMGN : 294.53 (+1.60%)
2 Vaccine Stocks to Buy on the Dip

Given the cutting-edge pipeline for these two vaccine companies, double-digit slumps in these stocks present a compelling entry point for investors.

AZN : 65.63 (+2.13%)
MRK : 99.18 (-0.68%)
LLY : 748.01 (-0.25%)
MRNA : 41.11 (+7.48%)
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Shares of Lilly are cratering, but investors may be surprised to learn what's influencing the volatility.

LLY : 748.01 (-0.25%)
J&J Loses Around $24B in a Month: How to Play the Stock?

J&J JNJ stock has plunged 6.1% in a month, losing almost $24 billion of its market value.Though slowing sales in its MedTech segment, the upcoming patent expiration of its blockbuster drug, Stelara, and...

NVO : 105.06 (+2.37%)
JNJ : 155.17 (-0.21%)
LLY : 748.01 (-0.25%)
KVUE : 24.08 (-0.04%)
The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan Stanley

For Immediate ReleaseChicago, IL – November 20, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

MS : 134.69 (-0.22%)
LLY : 748.01 (-0.25%)
PEP : 162.00 (+1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 774.03
2nd Resistance Point 767.66
1st Resistance Point 757.83
Last Price 748.01
1st Support Level 741.63
2nd Support Level 735.26
3rd Support Level 725.44

See More

52-Week High 972.53
Fibonacci 61.8% 815.57
Fibonacci 50% 767.09
Last Price 748.01
Fibonacci 38.2% 718.61
52-Week Low 561.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar